Jin Koo Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jin Koo Kim has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Paul H. Krebsbach
Division of Oral and Systemic Health Sciences, UCLA School of Dentistry, Los Angeles, CA 90095, USA
6 shared publications - Alexandra Fox
Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, Michigan. 2
2 shared publications Fei Liu
Department of Biologic and Materials Sciences, University of Michigan School of Dentistry , Ann Arbor, MI
2 shared publications- Joe Truong Nguyen
Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA
2 shared publications - Luis Gerardo Villa-Diaz
Department of Biological Sciences, Oakland University, Rochester Hills, MI 48309, USA
2 shared publications Younghun Jung
Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA
2 shared publications
Latest Publications
- 23 July 2024
- Published by Wiley in Rare Metals
- Vol. 44 (1) , 95-109
Three‐dimensional carbon microclusters organized by hollow carbon nanospheres for stable Li metal anodes: enabling high packing density and low tortuosity via self‐assembly
Recently, hollow carbon nanospheres (HCSs) have garnered significant attention as potential Li metal hosts owing to their unique large voids and ease of fabrication. However, similar to other nanoscale hosts, their practical performance is limited by inhomogeneous agglomeration, increased binder requirements, and high tortuosity within the electrode. To overcome these problems and high tortuosity within the electrode, this study introduces a pomegranate‐like carbon microcluster composed of primary HCSs (P‐CMs) as a novel Li metal host. This unique nanostructure can be easily prepared using the spray‐drying technique, enabling its mass production. Comprehensive analyses with various tools demonstrate that compared with HCS hosts, the P‐CM host requires a smaller amount of binder to fabricate a sufficiently robust and even surface electrode. Furthermore, owing to reduced tortuosity, the well‐designed P‐CM electrode can provide continuous and shortened pathways for electron/ion transport, accelerating the Li‐ion transfer kinetics and prohibiting preferential Li plating at the upper region of the electrode. Due to these characteristics, Li metal can be effectively encapsulated in the large inner voids of the primary HCSs constituting the P‐CM, thereby enhancing the electrochemical performance of P‐CM hosts in Li metal batteries. Specifically, the Coulombic efficiency of the P‐CM host can be maintained at 97% over 100 cycles, with a high Li deposition areal capacity of 3 mAh·cm −2 and long cycle life (1000 h, 1 mA·cm −2 , and 1.0 mAh·cm −2 ). Furthermore, a full cell incorporating a LiFePO 4 cathode exhibits excellent cycle life.
- 23 July 2024
- Published by Wiley in Rare Metals
- Vol. 44 (1) , 95-109
Three‐dimensional carbon microclusters organized by hollow carbon nanospheres for stable Li metal anodes: enabling high packing density and low tortuosity via self‐assembly
Recently, hollow carbon nanospheres (HCSs) have garnered significant attention as potential Li metal hosts owing to their unique large voids and ease of fabrication. However, similar to other nanoscale hosts, their practical performance is limited by inhomogeneous agglomeration, increased binder requirements, and high tortuosity within the electrode. To overcome these problems and high tortuosity within the electrode, this study introduces a pomegranate‐like carbon microcluster composed of primary HCSs (P‐CMs) as a novel Li metal host. This unique nanostructure can be easily prepared using the spray‐drying technique, enabling its mass production. Comprehensive analyses with various tools demonstrate that compared with HCS hosts, the P‐CM host requires a smaller amount of binder to fabricate a sufficiently robust and even surface electrode. Furthermore, owing to reduced tortuosity, the well‐designed P‐CM electrode can provide continuous and shortened pathways for electron/ion transport, accelerating the Li‐ion transfer kinetics and prohibiting preferential Li plating at the upper region of the electrode. Due to these characteristics, Li metal can be effectively encapsulated in the large inner voids of the primary HCSs constituting the P‐CM, thereby enhancing the electrochemical performance of P‐CM hosts in Li metal batteries. Specifically, the Coulombic efficiency of the P‐CM host can be maintained at 97% over 100 cycles, with a high Li deposition areal capacity of 3 mAh·cm −2 and long cycle life (1000 h, 1 mA·cm −2 , and 1.0 mAh·cm −2 ). Furthermore, a full cell incorporating a LiFePO 4 cathode exhibits excellent cycle life.
- Open Access
- 1 November 2023
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 42 (1) , 13-28
Selective Inhibition of mTORC1 Signaling Supports the Development and Maintenance of Pluripotency
Insight into the molecular mechanisms governing the development and maintenance of pluripotency is important for understanding early development and the use of stem cells in regenerative medicine. We demonstrate the selective inhibition of mTORC1 signaling is important for developing the inner cell mass (ICM) and the self-renewal of human embryonic stem cells. S6K suppressed the expression and function of pluripotency-related transcription factors (PTFs) OCT4, SOX2, and KLF4 through phosphorylation and ubiquitin proteasome-mediated protein degradation, indicating that S6K inhibition is required for pluripotency. PTFs inhibited mTOR signaling. The phosphorylation of S6 was decreased in PTF-positive cells of the ICM in embryos. Activation of mTORC1 signaling blocked ICM formation and the selective inhibition of S6K by rapamycin increased the ICM size in mouse blastocysts. Thus, selective inhibition of mTORC1 signaling supports the development and maintenance of pluripotency.
- 1 November 2023
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 42 (1) , 13-28
Open AccessSelective Inhibition of mTORC1 Signaling Supports the Development and Maintenance of Pluripotency
Insight into the molecular mechanisms governing the development and maintenance of pluripotency is important for understanding early development and the use of stem cells in regenerative medicine. We demonstrate the selective inhibition of mTORC1 signaling is important for developing the inner cell mass (ICM) and the self-renewal of human embryonic stem cells. S6K suppressed the expression and function of pluripotency-related transcription factors (PTFs) OCT4, SOX2, and KLF4 through phosphorylation and ubiquitin proteasome-mediated protein degradation, indicating that S6K inhibition is required for pluripotency. PTFs inhibited mTOR signaling. The phosphorylation of S6 was decreased in PTF-positive cells of the ICM in embryos. Activation of mTORC1 signaling blocked ICM formation and the selective inhibition of S6K by rapamycin increased the ICM size in mouse blastocysts. Thus, selective inhibition of mTORC1 signaling supports the development and maintenance of pluripotency.
- 22 June 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (10) , 8074-8083
Integrin alpha V beta 3 targeted dendrimer‐rapamycin conjugate reduces fibroblast‐mediated prostate tumor progression and metastasis
Therapeutic strategies targeting both cancer cells and associated cells in the tumor microenvironment offer significant promise in cancer therapy. We previously reported that generation 5 (G5) dendrimers conjugated with cyclic-RGD peptides target cells expressing integrin alpha V beta 3. In this study, we report a novel dendrimer conjugate modified to deliver the mammalian target of rapamycin (mTOR) inhibitor, rapamycin. In vitro analyses demonstrated that this drug conjugate, G5-FI-RGD-rapamycin, binds to prostate cancer (PCa) cells and fibroblasts to inhibit mTOR signaling and VEGF expression. In addition, G5-FI-RGD-rapamycin inhibits mTOR signaling in cancer cells more efficiently under proinflammatory condition compared to free rapamycin. In vivo studies established that G5-FI-RGD-rapamycin significantly inhibits fibroblast-mediated PCa progression and metastasis. Thus, our results suggest the potential of new rapamycin-conjugated multifunctional nanoparticles for PCa therapy. This article is protected by copyright. All rights reserved
- 22 June 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (10) , 8074-8083
Integrin alpha V beta 3 targeted dendrimer‐rapamycin conjugate reduces fibroblast‐mediated prostate tumor progression and metastasis
Therapeutic strategies targeting both cancer cells and associated cells in the tumor microenvironment offer significant promise in cancer therapy. We previously reported that generation 5 (G5) dendrimers conjugated with cyclic-RGD peptides target cells expressing integrin alpha V beta 3. In this study, we report a novel dendrimer conjugate modified to deliver the mammalian target of rapamycin (mTOR) inhibitor, rapamycin. In vitro analyses demonstrated that this drug conjugate, G5-FI-RGD-rapamycin, binds to prostate cancer (PCa) cells and fibroblasts to inhibit mTOR signaling and VEGF expression. In addition, G5-FI-RGD-rapamycin inhibits mTOR signaling in cancer cells more efficiently under proinflammatory condition compared to free rapamycin. In vivo studies established that G5-FI-RGD-rapamycin significantly inhibits fibroblast-mediated PCa progression and metastasis. Thus, our results suggest the potential of new rapamycin-conjugated multifunctional nanoparticles for PCa therapy. This article is protected by copyright. All rights reserved
- Open Access
- 4 May 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 4 (5) , eaao5838
Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration
Nematode EAK-7 (enhancer-of-akt-1-7) regulates dauer formation and controls life span; however, the function of the human ortholog mammalian EAK-7 (mEAK-7) is unknown. We report that mEAK-7 activates an alternative mechanistic/mammalian target of rapamycin (mTOR) signaling pathway in human cells, in which mEAK-7 interacts with mTOR at the lysosome to facilitate S6K2 activation and 4E-BP1 repression. Despite interacting with mTOR and mammalian lethal with SEC13 protein 8 (mLST8), mEAK-7 does not interact with other mTOR complex 1 (mTORC1) or mTOR complex 2 (mTORC2) components; however, it is essential for mTOR signaling at the lysosome. This phenomenon is distinguished by S6 and 4E-BP1 activity in response to nutrient stimulation. Conventional S6K1 phosphorylation is uncoupled from S6 phosphorylation in response to mEAK-7 knockdown. mEAK-7 recruits mTOR to the lysosome, a crucial compartment for mTOR activation. Loss of mEAK-7 results in a marked decrease in lysosomal localization of mTOR, whereas overexpression of mEAK-7 results in enhanced lysosomal localization of mTOR. Deletion of the carboxyl terminus of mEAK-7 significantly decreases mTOR interaction. mEAK-7 knockdown decreases cell proliferation and migration, whereas overexpression of mEAK-7 enhances these cellular effects. Constitutively activated S6K rescues mTOR signaling in mEAK-7–knocked down cells. Thus, mEAK-7 activates an alternative mTOR signaling pathway through S6K2 and 4E-BP1 to regulate cell proliferation and migration.
- 4 May 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 4 (5) , eaao5838
Open AccessMammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration
Nematode EAK-7 (enhancer-of-akt-1-7) regulates dauer formation and controls life span; however, the function of the human ortholog mammalian EAK-7 (mEAK-7) is unknown. We report that mEAK-7 activates an alternative mechanistic/mammalian target of rapamycin (mTOR) signaling pathway in human cells, in which mEAK-7 interacts with mTOR at the lysosome to facilitate S6K2 activation and 4E-BP1 repression. Despite interacting with mTOR and mammalian lethal with SEC13 protein 8 (mLST8), mEAK-7 does not interact with other mTOR complex 1 (mTORC1) or mTOR complex 2 (mTORC2) components; however, it is essential for mTOR signaling at the lysosome. This phenomenon is distinguished by S6 and 4E-BP1 activity in response to nutrient stimulation. Conventional S6K1 phosphorylation is uncoupled from S6 phosphorylation in response to mEAK-7 knockdown. mEAK-7 recruits mTOR to the lysosome, a crucial compartment for mTOR activation. Loss of mEAK-7 results in a marked decrease in lysosomal localization of mTOR, whereas overexpression of mEAK-7 results in enhanced lysosomal localization of mTOR. Deletion of the carboxyl terminus of mEAK-7 significantly decreases mTOR interaction. mEAK-7 knockdown decreases cell proliferation and migration, whereas overexpression of mEAK-7 enhances these cellular effects. Constitutively activated S6K rescues mTOR signaling in mEAK-7–knocked down cells. Thus, mEAK-7 activates an alternative mTOR signaling pathway through S6K2 and 4E-BP1 to regulate cell proliferation and migration.
- Open Access
- 27 March 2016
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 34 (7) , 1753-1764
Inhibition of Focal Adhesion Kinase Signaling by Integrin α6β1 Supports Human Pluripotent Stem Cell Self-Renewal
Self-renewal of human embryonic stem cells and human induced pluripotent stem cells (hiPSCs)—known as pluripotent stem cells (PSC)—is influenced by culture conditions, including the substrate on which they are grown. However, details of the molecular mechanisms interconnecting the substrate and self-renewal of these cells remain unclear. We describe a signaling pathway in hPSCs linking self-renewal and expression of pluripotency transcription factors to integrin α6β1 and inactivation of focal adhesion kinase (FAK). Disruption of this pathway results in hPSC differentiation. In hPSCs, α6β1 is the dominant integrin and FAK is not phosphorylated at Y397, and thus, it is inactive. During differentiation, integrin α6 levels diminish and Y397 FAK is phosphorylated and activated. During reprogramming of fibroblasts into iPSCs, integrin α6 is upregulated and FAK is inactivated. Knockdown of integrin α6 and activation of β1 integrin lead to FAK phosphorylation and reduction of Nanog, Oct4, and Sox2, suggesting that integrin α6 functions in inactivation of integrin β1 and FAK signaling and prevention of hPSC differentiation. The N-terminal domain of FAK, where Y397 is localized, is in the nuclei of hPSCs interacting with Oct4 and Sox2, and this immunolocalization is regulated by Oct4. hPSCs remodel the extracellular microenvironment and deposit laminin α5, the primary ligand of integrin α6β1. Knockdown of laminin α5 resulted in reduction of integrin α6 expression, phosphorylation of FAK and decreased Oct4. In conclusion, hPSCs promote the expression of integrin α6β1, and nuclear localization and inactivation of FAK to supports stem cell self-renewal.
- 27 March 2016
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 34 (7) , 1753-1764
Open AccessInhibition of Focal Adhesion Kinase Signaling by Integrin α6β1 Supports Human Pluripotent Stem Cell Self-Renewal
Self-renewal of human embryonic stem cells and human induced pluripotent stem cells (hiPSCs)—known as pluripotent stem cells (PSC)—is influenced by culture conditions, including the substrate on which they are grown. However, details of the molecular mechanisms interconnecting the substrate and self-renewal of these cells remain unclear. We describe a signaling pathway in hPSCs linking self-renewal and expression of pluripotency transcription factors to integrin α6β1 and inactivation of focal adhesion kinase (FAK). Disruption of this pathway results in hPSC differentiation. In hPSCs, α6β1 is the dominant integrin and FAK is not phosphorylated at Y397, and thus, it is inactive. During differentiation, integrin α6 levels diminish and Y397 FAK is phosphorylated and activated. During reprogramming of fibroblasts into iPSCs, integrin α6 is upregulated and FAK is inactivated. Knockdown of integrin α6 and activation of β1 integrin lead to FAK phosphorylation and reduction of Nanog, Oct4, and Sox2, suggesting that integrin α6 functions in inactivation of integrin β1 and FAK signaling and prevention of hPSC differentiation. The N-terminal domain of FAK, where Y397 is localized, is in the nuclei of hPSCs interacting with Oct4 and Sox2, and this immunolocalization is regulated by Oct4. hPSCs remodel the extracellular microenvironment and deposit laminin α5, the primary ligand of integrin α6β1. Knockdown of laminin α5 resulted in reduction of integrin α6 expression, phosphorylation of FAK and decreased Oct4. In conclusion, hPSCs promote the expression of integrin α6β1, and nuclear localization and inactivation of FAK to supports stem cell self-renewal.
- 20 June 2012
- Published by ASME International
- p. 1293-1294
Nanotopography Directs Fate of Human Embryonic Stem Cells
Human embryonic stem cells (hESCs) have remarkable potentials for breakthroughs in future cell-based therapeutics owing to their self-renewal capability and pluripotency [1–2]. However, their intrinsic mechanosensitivity to biophysical signals from the local cellular microenvironment is not well characterized [3–4]. In this work, we introduced a simple, yet precise, microfabrication strategy for accurate control and patterning of local nanoroughness on glass surfaces using photolithography and reactive ion etching (RIE). Our results demonstrated that nanoscale topological features could provide a potent regulatory signal over a diverse array of hESC behaviors, including their morphology, adhesion, proliferation and clonal expansion, and differentiation.
- 20 June 2012
- Published by ASME International
- p. 1293-1294
Nanotopography Directs Fate of Human Embryonic Stem Cells
Human embryonic stem cells (hESCs) have remarkable potentials for breakthroughs in future cell-based therapeutics owing to their self-renewal capability and pluripotency [1–2]. However, their intrinsic mechanosensitivity to biophysical signals from the local cellular microenvironment is not well characterized [3–4]. In this work, we introduced a simple, yet precise, microfabrication strategy for accurate control and patterning of local nanoroughness on glass surfaces using photolithography and reactive ion etching (RIE). Our results demonstrated that nanoscale topological features could provide a potent regulatory signal over a diverse array of hESC behaviors, including their morphology, adhesion, proliferation and clonal expansion, and differentiation.
- Open Access
- 15 March 2011
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 15 (1) , 45-51
Molecular and morphological evidence for the taxonomic status of a newly reported species ofAlbula(Albuliformes: Albulidae) from Korea and Taiwan
To clarify the taxonomic status of five specimens of Albula collected from Korea and Taiwan (Albula sp.), genetic differences among them and other congeneric species were investigated based on mitochondrial DNA cytochrome b sequences. All five specimens of Albula sp. showed identical haplotypes and strongly supported a monophyletic group on phylogenetic analysis. The genetic differences between Albula sp. and ten other species of Albula ranged from 0.100 to 0.164. These values were almost equal to or exceeded the interspecific differences among the latter ten species (0.038–0.206). Morphological comparisons of Albula sp. and another four Indo-Pacific species, A. argentea, A. glossodonta, A. oligolepis and A. virgata, are also presented. Albula sp. could be distinguished from the latter four species in their numbers of pored lateral-line scales, anal fin rays and vertebrae, as well as in several proportional measurements.
- 15 March 2011
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 15 (1) , 45-51
Open AccessMolecular and morphological evidence for the taxonomic status of a newly reported species ofAlbula(Albuliformes: Albulidae) from Korea and Taiwan
To clarify the taxonomic status of five specimens of Albula collected from Korea and Taiwan (Albula sp.), genetic differences among them and other congeneric species were investigated based on mitochondrial DNA cytochrome b sequences. All five specimens of Albula sp. showed identical haplotypes and strongly supported a monophyletic group on phylogenetic analysis. The genetic differences between Albula sp. and ten other species of Albula ranged from 0.100 to 0.164. These values were almost equal to or exceeded the interspecific differences among the latter ten species (0.038–0.206). Morphological comparisons of Albula sp. and another four Indo-Pacific species, A. argentea, A. glossodonta, A. oligolepis and A. virgata, are also presented. Albula sp. could be distinguished from the latter four species in their numbers of pored lateral-line scales, anal fin rays and vertebrae, as well as in several proportional measurements.